Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-314,643
Closed -$18.3M 67
2025
Q2
$18.3M Buy
314,643
+2,597
+0.8% +$147K 1.79% 17
2025
Q1
$15.5M Sell
312,046
-170,491
-35% -$8.72M 1.56% 24
2024
Q4
$21.6M Sell
482,537
-120
-0% -$5.7K 2.23% 18
2024
Q3
$23.2M Sell
482,657
-1,417
-0.3% -$68.3K 2.05% 18
2024
Q2
$24.6M Sell
484,074
-4,620
-0.9% -$253K 2.32% 16
2024
Q1
$26.6M Buy
488,694
+5,023
+1% +$262K 2.31% 13
2023
Q4
$27.4M Buy
483,671
+113,016
+30% +$6.39M 2.47% 12
2023
Q3
$23M Sell
370,655
-870
-0.2% -$55K 2.39% 14
2023
Q2
$22M Buy
371,525
+94,736
+34% +$6.03M 1.98% 19
2023
Q1
$20.4M Buy
276,789
+54,006
+24% +$4.17M 1.91% 21
2022
Q4
$16.3M Sell
222,783
-7,400
-3% -$585K 1.56% 23
2022
Q3
$19.3M Sell
230,183
-5,550
-2% -$477K 1.86% 20
2022
Q2
$18.7M Sell
235,733
-12,507
-5% -$1.21M 1.71% 24
2022
Q1
$25.7M Sell
248,240
-384,917
-61% -$31.9M 1.83% 22
2021
Q4
$47.7M Sell
633,157
-17,033
-3% -$1.19M 3.32% 12
2021
Q3
$42.2M Sell
650,190
-216,433
-25% -$13.2M 3.2% 13
2021
Q2
$52.6M Sell
866,623
-76,244
-8% -$4.51M 3.21% 12
2021
Q1
$50.8M Buy
942,867
+225,722
+31% +$12.3M 3.12% 13
2020
Q4
$34.5M Sell
717,145
-74,738
-9% -$3.3M 2.26% 17
2020
Q3
$31M Sell
791,883
-37,880
-5% -$1.38M 2.1% 18
2020
Q2
$26.6M Buy
+829,763
New +$28.9M 1.78% 18
2020
Q1
Sell
-1,210,210
Closed -$58M 69
2019
Q4
$58M Buy
1,210,210
+100,904
+9% +$4.88M 2.44% 17
2019
Q3
$73.2M Sell
1,109,306
-142,716
-11% -$7.28M 2.2% 18
2019
Q2
$87.7M Sell
1,252,022
-638,591
-34% -$33.3M 2.8% 16
2019
Q1
$133M Sell
1,890,613
-190,701
-9% -$9.94M 3.76% 13
2018
Q4
$133M Sell
2,081,314
-281,236
-12% -$14.7M 4.11% 11
2018
Q3
$176M Sell
2,362,550
-657,130
-22% -$36.4M 4.34% 10
2018
Q2
$216M Sell
3,019,680
-270,187
-8% -$13.4M 4.97% 8
2018
Q1
$200M Buy
+3,289,867
New +$165M 4.42% 10

Other funds holding NTR

QV Investors's NTR Position: Q3 2025 in Review

QV Investors sold out of Nutrien (NTR) in Q3 2025, closing a stake of 314,643 shares — an estimated $18.3M sold.

QV Investors first reported a position in NTR in Q1 2018 and held it in 29 quarters. The position peaked at $216M in Q2 2018. 645 funds tracked by Wall St. Rank hold NTR as of Q3 2025.

  • QV Investors reported no remaining Nutrien position as of Q3 2025 after selling out during the quarter.
  • QV Investors sold 314,643 Nutrien shares in Q3 2025, an estimated $18.3M.
  • QV Investors first reported a position in Nutrien in Q1 2018 and held it in 29 quarters.
  • QV Investors's Nutrien position peaked at $216M in Q2 2018.
  • 645 funds tracked by Wall St. Rank held Nutrien as of Q3 2025.

Based on QV Investors's 13F filing for Q3 2025, filed 30 Oct 2025.